Lycopene in the prevention of renal cell cancer in the TSC2 mutant Eker rat model
| dc.contributor.author | Şahin, Kazım | |
| dc.contributor.author | Cross, Brian | |
| dc.contributor.author | Şahin, Nurhan | |
| dc.contributor.author | Ciccone, Karina | |
| dc.contributor.author | Suleiman, Shadeah | |
| dc.contributor.author | Osunkoya, Adeboye O. | |
| dc.contributor.author | Küçük, Ömer | |
| dc.date.accessioned | 2026-08-12T17:32:32Z | |
| dc.date.issued | 2015 | |
| dc.department | Fırat Üniversitesi | |
| dc.description.abstract | Renal cell carcinoma (RCC) is the most frequent upper urinary tract cancer in humans and accounts for 80-85% of malignant renal tumors. Eker rat represents a unique animal model to study RCC since these rats develop spontaneous renal tumors and leiomyoma, which may be due to tuberous sclerosis 2 (TSC2) mutation resulting in the activation of the mammalian target of rapamycin (mTOR) pathway. This study examines the role of a lycopene-rich diet in the development of RCC in the TSC2 mutant Eker rat model. Ten-week old female Eker rats (n = 90) were assigned in equal numbers to receive 0, 100 or 200 mg/kg of lycopene as part of their daily diet. After 18 months the rats were sacrificed and the kidneys were removed. Immunohistochemical staining with antibodies against mTOR, phospho-S6 and EGFR were performed, as well as hematoxylin-eosin staining for histologic examination of the tumors. Tumors were counted and measured in individual kidneys. Presence of tumor decreased from 94% in control animals to 65% in the experimental group, but the difference was not statistically significant (P < 0.12). However, mean numbers of renal carcinomas were statistically significantly decreased in the lycopene-treated rats (P < 0.008) when compared to untreated controls. In the lycopene group, tumor numbers decreased (P < 0.002) and the numbers tended to decrease linearly (P < 0.003) as supplemental lycopene increased from 0 to 200. Control rats fed only basal diet had a greater length of tumors (23.98 mm) than rats fed lycopene supplement groups (12.90 mm and 11.07 mm) (P < 0.05). Moreover tumor length decreased (P < 0.02) and tumor length tended to decrease linearly (P < 0.03) as supplemental lycopene increased from 0 to 200 mg/kg. All tumors showed strong staining with antibodies against mTOR, phospho-S6 and EGER. In conclusion, dietary supplementation with lycopene attenuates the development of renal cell cancers in the predisposed TSC2 mutant Eker rat model. These results suggest that lycopene may play a role in the prevention of RCC. (C) 2015 Elsevier Inc. All rights reserved. | |
| dc.description.sponsorship | DSM, Basel, Switzerland; Georgia Cancer Coalition Carpenter Fellowship Fund (Karma Ciccone) | |
| dc.description.sponsorship | This research was supported in part by funds from DSM, Basel, Switzerland, and Georgia Cancer Coalition Carpenter Fellowship Fund (Karma Ciccone). Dr. Omer Kucuk is a Georgia Cancer Coalition Distinguished Cancer Scholar. | |
| dc.identifier.doi | 10.1016/j.abb.2015.01.006 | |
| dc.identifier.endpage | 39 | |
| dc.identifier.issn | 0003-9861 | |
| dc.identifier.issn | 1096-0384 | |
| dc.identifier.orcid | 0000-0002-5582-0028 | |
| dc.identifier.orcid | 0000-0001-9487-1154 | |
| dc.identifier.orcid | 0000-0001-9542-5244 | |
| dc.identifier.pmid | 25602702 | |
| dc.identifier.scopus | 2-s2.0-84932166197 | |
| dc.identifier.scopusquality | Q1 | |
| dc.identifier.startpage | 36 | |
| dc.identifier.uri | https://doi.org/10.1016/j.abb.2015.01.006 | |
| dc.identifier.uri | https://hdl.handle.net/11508/56665 | |
| dc.identifier.volume | 572 | |
| dc.identifier.wos | WOS:000353368900006 | |
| dc.identifier.wosquality | Q2 | |
| dc.indekslendigikaynak | Web of Science | |
| dc.indekslendigikaynak | Scopus | |
| dc.indekslendigikaynak | PubMed | |
| dc.language.iso | en | |
| dc.publisher | Elsevier Science Inc | |
| dc.relation.ispartof | Archives of Biochemistry and Biophysics | |
| dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | |
| dc.rights | info:eu-repo/semantics/openAccess | |
| dc.snmz | KA_WoS_20260511 | |
| dc.subject | Renal cell cancer | |
| dc.subject | Lycopene | |
| dc.subject | Eker rat | |
| dc.title | Lycopene in the prevention of renal cell cancer in the TSC2 mutant Eker rat model | |
| dc.type | Article |







